(Q28221566)

1

0 references

Peter A Kouides

2

0 references

Mary Ann Tara

3

0 references

William A Fricke

Expert Review of Cardiovascular Therapy

4

0 references

language of work or name

English

0 references

publication date

September 2007

0 references

published in

0 references

volume

5

0 references

issue

5

0 references

page(s)

955-67

0 references

cites work

Platelet functional defects in women with unexplained menorrhagia

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

Evaluation of platelet function with the PFA-100 system in patients with congenital defects of platelet secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

The preoperative bleeding time test lacks clinical benefit: College of American Pathologists' and American Society of Clinical Pathologists' position article

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

THE RELATION OF BLOOD PLATELETS TO HEMORRHAGIC DISEASE

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

The bleeding time as a screening test for evaluation of platelet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

Can the Platelet Function Analyzer (PFA)-100 test substitute for the template bleeding time in routine clinical practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

Antigen Generation in Heparin-Associated Thrombocytopenia: The Nonimmunologic Type and the Immunologic Type Are Closely Linked in Their Pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

The Platelet Function Analyzer (PFA-100): a novel in-vitro system for evaluation of primary haemostasis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

Influence of ABO blood groups on primary hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

Clinical relevance of aspirin resistance in patients with stable coronary artery disease: a prospective follow-up study (PROSPECTAR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

Influence of systemic inflammation on the interpretation of response to antiplatelet therapy, monitored by PFA-100

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

The utility of the PFA-100 in the identification of von Willebrand disease: a concise review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

Utility of the PFA-100 for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

Using the Platelet Function Analyzer-100 for monitoring aspirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

The platelet inhibiting effect of a clopidogrel bolus dose in patients on long-term acetylsalicylic acid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

A practical concept for preoperative management of patients with impaired primary hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

A practical concept for preoperative identification of patients with impaired primary hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

A critical reappraisal of the bleeding time

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

Approach to the assessment of platelet function: comparison between optical-based platelet-rich plasma and impedance-based whole blood platelet aggregation methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

The effect of a loading dose (300 mg) of clopidogrel on platelet function in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

Flow cytometry of platelets for clinical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

Flow cytometry detection of serotonin content and release in resting and activated platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

Aspirin and clopidogrel resistance: an emerging clinical entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

Aspirin resistance: definition, mechanisms and clinical read-outs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

Aspirin resistance: position paper of the Working Group on Aspirin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

Resistance to clopidogrel: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

Aspirin resistance: is it real? Is it clinically significant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

Evidence that pre-existent variability in platelet response to ADP accounts for 'clopidogrel resistance'

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

A flow cytometric assay using mepacrine for study of uptake and release of platelet dense granule contents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955

Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.5.5.955